Andrew Hong

[Men in Blazers @MenInBlazers]

SIDNY LOPES CABRAL CAN'T BELIEVE IT, AND NEITHER CAN WE 😱

STOP YOUR SCROLL WATCH THE GOAL OF THE 2026 WORLD CUP 🇨🇻

[Andrew Hong @hongdrew]

@45PedroMartinez Pedro, how bout you do both, and launch a few fastballs at the rabbits who eat my peas? A few heaters to protect the plot and they should hop away 🐰 ⚾️ 💨

[Andrew Hong @hongdrew]

@bradloncar What supports AZ’s conviction in TIGIT / rivegostomig, when target as a whole has not met expectations? Broader insights for PD1 bispec

[Jacob Plieth @JacobPlieth]

Wow, #Asco26 discussant Julie Brahmer is distinctly restrained (OK, scathing!) in her enthusiasm for Harmoni-6 $SMMT

[Parmita Mishra @parmita]

RAS finally getting drugged is one of the great stories in modern biology, and almost nobody outside oncology understands why it's such a big deal.

YOU'LL LEARN SOMETHING AWESOME TODAY.

i am going to keep this as understandable (and simple) as i can.

OPEN THE THREAD.

🧵

[Samuel Hume @DrSamuelBHume]

How outcomes in relapsed/refractory multiple myeloma changed, from 1986 to 2026

[Andrew Hong @hongdrew]

@brihreed is now in 3rd place @signalawards Listener’s Choice #signalawards. RT + VOTE: https://t.co/ceUZyw0xi0

[Andrew Hong @hongdrew]

@brihreed is now in 5th place @signalawards Listener’s Choice #signalawards. RT + VOTE: https://t.co/KY8W9LDpPZ

[Andrew Hong @hongdrew]

I interviewed Dr. Camidge over the years to hear his perspectives on novel treatments for lung cancer. He is thoughtful, direct, honest, and shares wisdom with trademark humor. Learning his personal story is an inspiration

[Stephen V Liu, MD @StephenVLiu]

One of the biggest influences on my career is Dr. Ross Camidge - a mentor and friend, an intellectual giant in the field of lung cancer who was diagnosed with this unforgiving disease himself. We are all at risk - and must all work to move the field.

https://t.co/GHuaFBUoBm

[MBTA @MBTA]

New top speed reached! For the first time, the Orange Line is running at a max speed of 55mph between Oak Grove and Assembly. Previously maxing out at 40mph, we're excited to deliver infrastructure upgrades that lead to faster service and time savings.

⏩https://t.co/kBO4zFIvyA

[Andrew Hong @hongdrew]

@HosseinBorghaei Wonderful to see! Congratulations

[Dr Amol Akhade @SuyogCancer]

Useful slide to explain clinical outcomes for pts with 1st line, 2nd line and Beyond For HR+ /Her2 -ve MBC . Money 💰 slide by @jhaveri_komal @asco #asco25 @OncoAlert @OncBrothers

[Ilana Schlam @IlanaSchlam]

#ASCO2025 was filled with groundbreaking science. Feeling inspired and grateful to be part of this community. These are just a few of the top breast cancer studies presented, and some of the remaining questions.

[Tom Newsom-Davis @tnewsomdavis]

TROPION-Lung02
Dato-DXd + Pembro +/- chemo

❗️Data on TROP2 NMR QCS
👉Approx 50% NMR+
✅mPFS TROP2+ = 12 vs 8.1m
✅Esp ⬆️ in doublet regimen

🤔 Numbers small, interpret with caution
🤔 Retrospective NMR analysis
🤔 But NMR proving itself in clinical studies

#ASCO25 #LCSM

[Jordi Remon @JordiRemon]

Pembro +adagrasib in KRAS G12C NSCLC all comers in 1st L. Outcome in all PDL1 strata mirroring CT+IO. Can we spare chemo in these pts regardless of PDL1 expression or just for high PDL1?Better outcomes with chemo-adagrasib-pembro but higher tox? IcORR? #ASCO25

[Andrew Hong @hongdrew]

@SophiePurdom @planeteercap @ychernova @WSJ Great to see!

[Vatican News @VaticanNews]

White smoke! The 133 Cardinal electors gathered in the Vatican’s Sistine Chapel have elected the new Pope. He will appear soon at the central window of St. Peter’s Basilica.

[Adam Menges @adammenges]

I love prototyping. It’s the most important thing that sets great software above the merely good.

And to that end, here’s a project a couple of us have been hacking away on, and the team is ready to add people in mass to the TestFlight. It’s an open source version of a visual programming environment, similar to Origami or Quartz Composer.

In addition to being able to build anything those two can, it also supports AR, CoreML, and native 3D support. As well as being built in SwiftUI, so it runs on basically any Apple device and is easy to hack on and improve.